A Study of AK119 (Anti-CD73 Antibody), a Treatment for COVID-19, in Healthy Subjects

NCT04516564 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

29

Enrollment

INDUSTRY

Sponsor class

Conditions

Coronavirus Disease 2019 (COVID-19)

Interventions

DRUG: AK119
DRUG: Placebo

Sponsor

Akesobio Australia Pty Ltd